Clinical Outcome Following Second-Generation Drug-Eluting Stent Use for Off-Label Versus On-Label Indications: Insights From the Two-Year Outcome of the TWENTE Trial
EuroIntervention - France
doi 10.4244/eijv10i6a117
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2014
Authors
Publisher
Europa Digital & Publishing